Obesity and renal hemodynamics.

Obesity is a risk factor for renal damage in native kidney disease and in renal transplant recipients. Obesity is associated with several renal risk factors such as hypertension and diabetes that may convey renal risk, but obesity is also associated with an unfavorable renal hemodynamic profile independent of these factors, and that may exert effects on renal damage as well. In animal models of obesity-associated renal damage, micro-puncture studies showed glomerular hypertension and hyperfiltration. In humans an elevated glomerular filtration rate has been demonstrated in several studies, sometimes associated with hyperperfusion as well, independent of blood pressure or the presence of diabetes. An elevated filtration fraction was found in several studies, consistent with glomerular hypertension. This renal hemodynamic profile resembles the hyperfiltration pattern in diabetes and is therefore assumed to be a pathogenetic factor in renal damage. Of note, the association between body mass index and renal hemodynamics is not limited to overt obesity or overweight, but is also present across the normal range, without a particular threshold. Multiple factors are assumed to contribute to these renal hemodynamic alterations, such as insulin resistance, the renin-angiotensin system and the tubulo-glomerular responses to increased proximal sodium reabsorption, and possibly also inappropriate activity of the sympathetic nervous system and increased leptin levels. Obesity has a high world-wide prevalence. On a population-basis, therefore, its contribution to long-term renal risk may be considerable, especially as it is usually clustered with risk factors like hypertension and insulin resistance. In short-term studies the renal hemodynamic alterations in obesity and the associated proteinuria were reversible by weight loss, and renin-angiotensin system-blockade, respectively. These interventions are therefore likely to have the potential to limit the renal risks of obesity.

[1]  S. T. Boyd,et al.  Update on Rimonabant—A Selective Cannabinoid CB1 Antagonist , 2006, The Annals of pharmacotherapy.

[2]  T. Srivastava Nondiabetic consequences of obesity on kidney , 2006, Pediatric Nephrology.

[3]  N. Hollenberg,et al.  Body Mass Index and Angiotensin-Dependent Control of the Renal Circulation in Healthy Humans , 2005, Hypertension.

[4]  G. Navis,et al.  Predictive Performance of Renal Function Equations in Renal Transplant Recipients: An Analysis of Patient Factors in Bias , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  M. Cirillo,et al.  Relationship of gender, age, and body mass index to errors in predicted kidney function. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  A. Mark,et al.  Role of selective leptin resistance in diet-induced obesity hypertension. , 2005, Diabetes.

[7]  A. Rodríguez,et al.  Morbid Obesity, Hypertensive Disease and the Renin-Angiotensin-Aldosterone Axis , 2005, Obesity surgery.

[8]  M. Wofford,et al.  Pathophysiology and treatment of obesity hypertension. , 2004, Current pharmaceutical design.

[9]  R. Gans,et al.  Metabolic Syndrome Is Associated with Impaired Long‐term Renal Allograft Function; Not All Component criteria Contribute Equally , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  K. Żwirska-Korczala,et al.  Influence of intravenously administered leptin on nitric oxide production, renal hemodynamics and renal function in the rat , 2004, Regulatory Peptides.

[11]  M. Ghoneim,et al.  WEIGHT GAIN AFTER RENAL TRANSPLANTATION IS A RISK FACTOR FOR PATIENT AND GRAFT OUTCOME , 2004, Transplantation.

[12]  A. Aviv,et al.  Sodium glomerulopathy: tubuloglomerular feedback and renal injury in African Americans. , 2004, Kidney international.

[13]  T. Weinstein,et al.  The effects of weight loss on renal function in patients with severe obesity. , 2003, Journal of the American Society of Nephrology : JASN.

[14]  G. Navis,et al.  A central body fat distribution is related to renal function impairment, even in lean subjects. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  John E. Hall,et al.  Obesity-associated hypertension and kidney disease , 2003, Current opinion in nephrology and hypertension.

[16]  John E Hall,et al.  The kidney, hypertension, and obesity. , 2003, Hypertension.

[17]  K. Rahmouni,et al.  Leptin and the central neural mechanisms of obesity hypertension. , 2002, Drugs of Today.

[18]  H. Hillege,et al.  Obesity and target organ damage: the kidney , 2002, International Journal of Obesity.

[19]  N. Hollenberg,et al.  Type 2 diabetes, obesity, and the renal response to blocking the renin system with irbesartan , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[20]  M. Mitsnefes,et al.  Body mass index and allograft function in pediatric renal transplantation , 2002, Pediatric Nephrology.

[21]  H. Meier‐Kriesche,et al.  The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. , 2002, Transplantation.

[22]  N. Hollenberg Sodium and the kidney: the non-modulator concept. , 2001, Nephrology, Dialysis and Transplantation.

[23]  E. Morales,et al.  Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  S. Bigler,et al.  Functional and structural changes in the kidney in the early stages of obesity. , 2001, Journal of the American Society of Nephrology : JASN.

[25]  J. Hall,et al.  Obesity hypertension: role of leptin and sympathetic nervous system. , 2001, American journal of hypertension.

[26]  F. Berthoux,et al.  Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  V. D’Agati,et al.  Obesity-related glomerulopathy: an emerging epidemic. , 2001, Kidney international.

[28]  S. Engeli,et al.  Role of Adipose Tissue for Cardiovascular-Renal Regulation in Health and Disease , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[29]  A. Fukamizu,et al.  Angiotensinogen, angiotensin II and adipose tissue development , 2000, International Journal of Obesity.

[30]  M. Burnier,et al.  Proximal Sodium Reabsorption: An Independent Determinant of Blood Pressure Response to Salt , 2000, Hypertension.

[31]  R. Pollastro,et al.  Glomerular filtration rate in severely overweight normotensive humans. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[32]  T. Weinstein,et al.  Glomerular hemodynamics in severe obesity. , 2000, American journal of physiology. Renal physiology.

[33]  G. Friedman,et al.  The effect of body mass index on long-term renal allograft survival. , 1999, Transplantation.

[34]  J. Schnermann,et al.  The macula densa is worth its salt. , 1999, The Journal of clinical investigation.

[35]  J. T. ter Maaten,et al.  Insulin's acute effects on glomerular filtration rate correlate with insulin sensitivity whereas insulin's acute effects on proximal tubular sodium reabsorption correlation with salt sensitivity in normal subjects. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[36]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[37]  W. Ambrosius,et al.  Serum angiotensinogen concentration in relation to gonadal hormones, body size, and genotype in growing young people. , 1998, Hypertension.

[38]  A. Distler,et al.  Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men , 1998, Journal of hypertension.

[39]  N. Hollenberg,et al.  Obesity, Salt Intake, and Renal Perfusion in Healthy Humans , 1998 .

[40]  G. Jennings,et al.  Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. , 1997, Circulation.

[41]  E. Ferrannini,et al.  Renal effects of insulin in man. , 1997, Journal of nephrology.

[42]  K. Salmela,et al.  Is obesity still a risk factor in renal transplantation? , 1997, Transplant international : official journal of the European Society for Organ Transplantation.

[43]  D. Owens,et al.  Estimation of glomerular filtration rate in type II (non-insulin dependent) diabetes mellitus patients. , 1997, IMA journal of mathematics applied in medicine and biology.

[44]  C. Rotimi,et al.  Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. , 1997, Circulation.

[45]  D. Fliser,et al.  Renal function in the elderly: impact of hypertension and cardiac function. , 1997, Kidney international.

[46]  D. Jarjoura,et al.  Geriatric renal function: estimating glomerular filtration in an ambulatory elderly population. , 1997, Clinical nephrology.

[47]  D. de Zeeuw,et al.  A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function. , 1997, Kidney international.

[48]  J. Coresh,et al.  Evaluation of serum creatinine for estimating glomerular filtration rate in African Americans with hypertensive nephrosclerosis: results from the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study. , 1997, Journal of the American Society of Nephrology : JASN.

[49]  J. Hall,et al.  Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity. , 1996, Hypertension.

[50]  A. Goldberg,et al.  Insulin resistance, elevated glomerular filtration fraction, and renal injury. , 1996, Hypertension.

[51]  J. Lalouel,et al.  Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity , 1996, Journal of hypertension.

[52]  P. van Paassen,et al.  Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension? , 1996, Hypertension.

[53]  A. Mimran,et al.  Combined renal effects of overweight and hypertension. , 1995, Hypertension.

[54]  L. Ruilope,et al.  Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. , 1995, Nephron.

[55]  J. Chapman,et al.  Predicting glomerular filtration rate after kidney transplantation. , 1995, Transplantation.

[56]  H. Parving,et al.  Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. , 1995, Kidney international.

[57]  S. Corrao,et al.  Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[58]  J. Chapman,et al.  Predicting glomerular filtration rate after simultaneous pancreas and kidney transplantation. , 1995, Clinical transplantation.

[59]  R. Schmieder,et al.  How should renal hemodynamic data be indexed in obesity? , 1995, Journal of the American Society of Nephrology.

[60]  S. K. Park,et al.  Renal Function and Hemodynamic Study in Obese Zucker Rats , 1995, The Korean journal of internal medicine.

[61]  S. Bianchi,et al.  Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. , 1994, Hypertension.

[62]  M. Walser,et al.  Prediction of glomerular filtration rate from serum creatinine concentration in advanced chronic renal failure. , 1993, Kidney international.

[63]  J. Hall,et al.  Obesity-induced hypertension. Renal function and systemic hemodynamics. , 1993, Hypertension.

[64]  C. Anderson,et al.  Glomerular hemodynamic alterations during acute hyperinsulinemia in normal and diabetic rats. , 1992, Kidney international.

[65]  B. Kasiske,et al.  Renal injury in obese Zucker rats: glomerular hemodynamic alterations and effects of enalapril. , 1992, The American journal of physiology.

[66]  V. Campese,et al.  Abnormal Renal Hemodynamics in Black Salt-Sensitive Patients With Hypertension , 1991, Hypertension.

[67]  S. Heymsfield,et al.  Relative expansion of extracellular fluid in obese vs. nonobese women. , 1991, The American journal of physiology.

[68]  J. Hall,et al.  Chronic intrarenal hyperinsulinemia does not cause hypertension. , 1991, The American journal of physiology.

[69]  V. Katch,et al.  The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. , 1989, The New England journal of medicine.

[70]  L. Landsberg,et al.  Obesity, metabolism, and the sympathetic nervous system. , 1989, American journal of hypertension.

[71]  W. Deen,et al.  "Intact nephrons" as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy. , 1988, The Journal of clinical investigation.

[72]  D. Salazar,et al.  Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. , 1988, The American journal of medicine.

[73]  A. Fogo,et al.  Serial micropuncture analysis of single nephron function in subtotal renal ablation. , 1988, Kidney international.

[74]  E. Frohlich,et al.  Renal Haemodynamic Studies in Obesity Hypertension , 1987, Journal of hypertension.

[75]  O. Iimura,et al.  The pathophysiological role of water-sodium balance and renal dopaminergic activity in overweight patients with essential hypertension. , 1987, Journal of clinical hypertension.

[76]  N. Hollenberg,et al.  Abnormal Renal Sodium Handling in Essential Hypertension Relation to Failure of Renal and Adrenal Modulation of Responses to Angiotensin II , 1986 .

[77]  B. Kasiske,et al.  Effects of genetic obesity on renal structure and function in the Zucker rat. , 1985, The Journal of laboratory and clinical medicine.

[78]  R. L. Hall,et al.  Captopril slows the progression of chronic renal disease in partially nephrectomized rats. , 1985, Toxicology and applied pharmacology.

[79]  N W Shock,et al.  Longitudinal Studies on the Rate of Decline in Renal Function with Age , 1985, Journal of the American Geriatrics Society.

[80]  G. F. Gates,et al.  Creatinine clearance estimation from serum creatinine values: an analysis of three mathematical models of glomerular function. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[81]  K. Minaker,et al.  Influence of Age on Clearance of Insulin in Man , 1982, Diabetes.

[82]  B. Brenner,et al.  Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. , 1981, The American journal of physiology.

[83]  G. Koch,et al.  Influence of range of renal function and liver disease on predictability of creatinine clearance , 1981, Clinical pharmacology and therapeutics.

[84]  J W Rowe,et al.  Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man , 1981, Diabetes.

[85]  S. Welle,et al.  Increased plasma norepinephrine concentrations and metabolic rates following glucose ingestion in man. , 1980, Metabolism: clinical and experimental.

[86]  T. Bjornsson Use of Serum Creatinine Concentrations to Determine Renal Function1 , 1979, Clinical pharmacokinetics.

[87]  Roger W. Jelliffe,et al.  Creatinine Clearance: Bedside Estimate , 1973 .

[88]  S B Lucas,et al.  Computer-assisted prescribing of kanamycin for patients with renal insufficiency. , 1972, Lancet.

[89]  R W Jelliffe,et al.  Estimation of creatinine clearance when urine cannot be collected. , 1971, Lancet.

[90]  H. M. Whyte,et al.  Plasma creatinine level and creatinine clearance as tests of renal function. , 1959, Australasian annals of medicine.

[91]  G. Navis,et al.  Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. , 2004, Kidney international.

[92]  T. Larson,et al.  Measured and estimated GFR in healthy potential kidney donors. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[93]  T. Dwyer,et al.  Is obesity a major cause of chronic kidney disease? , 2004, Advances in renal replacement therapy.

[94]  T. Lüscher,et al.  Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin. , 2000, Hypertension.

[95]  L. Landsberg Insulin resistance, energy balance and sympathetic nervous system activity. , 1990, Clinical and experimental hypertension. Part A, Theory and practice.

[96]  B. Kasiske,et al.  Effects of genetic obesity on renal structure and function in the Zucker rat. II. Micropuncture studies. , 1985, The Journal of laboratory and clinical medicine.

[97]  B. Kasiske,et al.  Glomerular sclerosis in patients with massive obesity. , 1985, American journal of nephrology.

[98]  B. Brenner,et al.  Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. , 1983, Kidney international.

[99]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .